#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16736	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2034	814.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1383	1383	C	977	C,T	897,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31400	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	894.3	0	.	n	.	0	T695C	SNP	695	695	T	997	997	C	989	C	923	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31400	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	894.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1940	1940	G	1011	G,A,T	945,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31400	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	894.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2273	2273	C	992	C,T	912,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31400	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	894.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2347	2347	A	1000	A	938	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31400	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	894.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2899	2899	C	933	C	870	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1958	folP	855	855	100.0	folP.l15.c4.ctg.1	1505	129.4	1	SNP	p	R229S	1	.	.	685	687	AGC	937	939	AGC	195;192;193	A;G;C	183;185;184	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	173.3	1	SNP	p	S91F	1	.	.	271	273	TTC	616	618	TTC	190;187;186	T;T;C	176;170;168	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	173.3	1	SNP	p	G95N	0	.	.	283	285	GGC	628	630	GGC	188;184;182	G;G;C	176;173;169	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	173.3	1	SNP	p	D95G	1	.	.	283	285	GGC	628	630	GGC	188;184;182	G;G;C	176;173;169	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1672	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1360	122.4	1	SNP	p	G45D	0	.	.	133	135	GGC	438	440	GGC	216;215;213	G;G;C	202;201;197	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	806	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1072	74.7	0	.	n	.	0	A197.	DEL	197	197	A	670	670	A	199	A	187	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3220	193.1	1	SNP	p	D86N	0	.	.	256	258	GAC	676	678	GAC	258;257;256	G;A;C	242;233;239	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3220	193.1	1	SNP	p	R87I	0	.	.	259	261	CGT	679	681	CGT	256;254;255	C;G;T	240;239;235	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3220	193.1	1	SNP	p	S87R	1	.	.	259	261	CGT	679	681	CGT	256;254;255	C;G;T	240;239;235	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3220	193.1	1	SNP	p	R87W	0	.	.	259	261	CGT	679	681	CGT	256;254;255	C;G;T	240;239;235	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3220	193.1	1	SNP	p	S88P	0	.	.	262	264	TCC	682	684	TCC	254;255;253	T;C;C,T	241;243;239,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4096	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2531	160.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1479	1481	GGC	184;184;181	G;G;C	174;170;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1209	1211	GCC	199;200;198	G;C;C	181;185;185	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1212	1214	ATG	198;196;196	A;T;G	185;183;184	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1224	1226	ACC	200;200;202	A;C;C	183;186;186	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1224	1226	ACC	200;200;202	A;C;C	183;186;186	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1725	1727	ACC	215;213;214	A;C,T;C	197;197,1;201	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1779	1781	GCG	202;203;200	G;C,G;G	178;179,1;179	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1779	1781	GCG	202;203;200	G;C,G;G	178;179,1;179	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1902	1904	GGT	175;175;176	G;G;T	160;158;157	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1911	1913	AGC	164;161;159	A;G;C	152;152;143	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4140	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	176.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1929	1931	CCG	146;151;152	C,G;C;G	116,6;118;122	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6194	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3189	193.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1618	1620	CCG	251;247;244	C;C;G	217;219;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2340	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1821	127.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	540	540	C	146	C	133	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	338	porB1a	984	331	90.15	porB1a.l15.c17.ctg.2	487	27.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	175	177	AAT	22;22;22	A;A;T	22;22;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	338	porB1a	984	331	90.15	porB1a.l15.c17.ctg.2	487	27.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	178	180	AAT	23;23;23	A;A;T	23;23;23	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	338	porB1a	984	331	90.15	porB1a.l15.c17.ctg.2	487	27.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	202	204	GCA	23;23;23	G;C;A	23;23;23	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	338	porB1a	984	331	90.15	porB1a.l15.c17.ctg.2	487	27.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	225	227	GTA	20;20;20	G;T;A	20;20;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	338	porB1a	984	331	90.15	porB1a.l15.c17.ctg.2	487	27.0	0	.	p	.	0	N237fs	FSHIFT	709	709	A	234	234	A	18	A	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3378	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1613	207.6	1	SNP	p	G120K	1	.	.	358	360	AAG	668	670	AAG	254;255;253	A;A;G,C	236;239;228,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3378	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1613	207.6	1	SNP	p	A121N	1	.	.	361	363	AAC	671	673	AAC	257;258;259	A;A;C	237;239;236	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3378	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1613	207.6	1	SNP	p	N121D	0	.	.	361	363	AAC	671	673	AAC	257;258;259	A;A;C	237;239;236	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12682	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4760	265.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1326	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	969	135.8	1	SNP	p	V57M	1	.	.	169	171	ATG	440	442	ATG	284;290;288	A;T;G	265;272;268	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
